U.S. is Expected to Fuel the Growth of the North America Dermatology Devices Market in the Future Years 2016 to 2022" – a New Report by Data Bridge Market Research

Dallas, TX, March 27, 2016 --(PR.com)-- The increasing incidences of skin disorders, such as melanoma & non-melanoma skin cancer, vascular & pigmented lesions, varicose veins, psoriasis, and acne, coupled with increasing awareness amongst the population has triggered the market for both diagnostic and treatment devices. In the U.S., melanoma accounted for about 3.0% of the skin cancer cases found, with 70,000-80,000 new cases being diagnosed, annually. Superficial spreading melanoma was found to be one of the most common forms of melanoma, encompassing 65.0% of the total melanomas cases registered. This type of melanoma arises in a pre-existing mole, growing horizontally before invading vertically. According to the latest statistics made available by National Cancer Institute, about 2.5 to 3.0 million skin lesions were biopsied in the U.S., of which melanoma represents less than 5% of skin cancer. In 2012, 44,250 men and 32,000 women were diagnosed with melanoma of the skin, and 8700 of these total cases resulted in death.

Dermatology devices are used by dermatologists and surgeons to diagnose skin disorders and accurately determine its type. Dermatology devices are categorized into two segments- the diagnostic devices market and treatment devices market. Treatment devices form a major segment of the dermatology devices market that consists of devices, such as electrosurgical equipment, liposuction devices, LED light therapy devices, microdermabrasion, and various types of lasers, such as carbon-dioxide lasers, argon lasers, diode laser, ND:YAG (neodymium-doped yttrium aluminum garnet) laser, and intense pulse light laser (IPL). Among all the treatment devices, LED light therapy devices accounted for the largest share of the dermatology treatment devices market in 2015.

Technical advances in the diagnostic devices as well as treatment devices had a positive impact on the dermatology devices market in the recent past. Advancements in diagnostic devices, such as the recently launched (January 2011) handyscope by FotoFinder helps doctors capture images of a particular skin disorder and send files to the dermatologist for diagnosis and treatment. This is expected to not only boost the diagnostic device market, but will also be a driver for the growth of the tele-dermatology market, as critical medical information can be exchanged over a distance using audio and visual data communication.

The dermatology diagnostic devices segment is further segmented into dermatoscopes, microscopes, and imaging techniques. Dermatoscope is the most commonly used device to diagnose various skin disorders, due to the high level of accuracy that it provides. Microscopes help with an early and rapid diagnosis of the skin disorder, whereas, imaging techniques such as MRI, CT, ultrasound, and OCT scanners, increase the speed of the diagnosis of skin disorders at an earlier stage.

The North America dermatology devices market is expected to reach USD 5.9 billion by 2022, growing at a CAGR of 9.2% in the forecasted period. The market is expected to experience a prolific growth in the forecasted period due to the high prevalence of skin related disorders. Apart from this the increased funding in healthcare and increased spending and awareness for aesthetic procedures is fueling the growth of this market.

By geography the dermatology devices market is segmented into 3 countries U.S. Canada and Mexico. U.S. dominates the market in 2015 followed by Canada and Mexico. Based on End-Users the dermatology devices are mostly used in hospitals in 2015 followed by clinics and other segments.

Developments in treatment options such as IPL (intense pulse light), a non-invasive technique to treat skin disorders that is comparatively gentler, requires minimal time for recovery and is easy to administer when compared to other types of laser treatments. The emerging technology of multispectral imaging in the spatial domain has revolutionized the entire approach of the diagnosis of melanoma. Automatic data analysis algorithms are further utilized to analyze data quality control (detection of imaging problems, such as overexposure, underexposure, inappropriate lesion size, excess hair, and so on). A classic example of such a device is MelaFind [MELA Sciences, Inc. (U.S.)]. The multispectral method in the spectral domain uses radiation data for a point or region and presents it as a function of frequency or wavelength. This involves IR (infrared) and Raman spectroscopy.

Heine Optotechnik, OptomedOy, FotoFinder Systems, Michelson diagnostics, Genesis Biosystems, Ellipse A/S, Alma Lasers, Palomar Technologies, GE Healthcare, Philips Healthcare, Verisante Technology, Inc., MELA Sciences, Inc., Verisante Technology, Inc., Welch Allyn, Carl Zeiss Meditec, Inc., Hitachi, Leica Microsystems, Olympus, GE Healthcare, Phillips Healthcare, Toshiba Medical Systemsand Siemens Medical Systems, are some of the key players engaged in this market.

Mail sales@databridgemarketresearch.com

Or visit

http://databridgemarketresearch.com/reports/north-america-dermatology-devices-market/